Hepatitis C treatment with triple therapy in a patient with hemophilia A

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

319

HTML

2471

Figures (1-1)

274

Sum=3064

Publishing Process of This Article

Item

Count

Browse

930

Download

756

Sum=1686

Jun 16, 2013 (publication date) through Nov 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jun 16, 2013; 1(3): 106-107
Published online Jun 16, 2013. doi: 10.12998/wjcc.v1.i3.106

Figure 1 A graph demonstrating factor VIII levels and dosage while on telaprevir-based triple therapy.

Citation: Singh G, Sass R, Alamiry R, Zein N, Alkhouri N. Hepatitis C treatment with triple therapy in a patient with hemophilia A. World J Clin Cases 2013; 1(3): 106-107
URL: https://www.wjgnet.com/2307-8960/full/v1/i3/106.htm
DOI: https://dx.doi.org/10.12998/wjcc.v1.i3.106